TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
BLLN

BillionToOne, Inc.

Healthcare · Diagnostics & Research

94.00$ -3.5% vs. previous close Closing price · As of: Aug 13, 2026

Ownership

Ownership Structure

Who owns BillionToOne, Inc. (BLLN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 35.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 37.1%

Largest Shareholders

No ownership data is available for this stock yet.

Insider holdings

Insider holdings BLLN
Person Role Shares Value As of Type
ten Bosch John Roderick SVP of Laboratory Operations 27,884 2,621,096 $ Aug 10, 2026 direct
Tsao David Chief Technology Officer 1,000 94,000 $ Aug 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 10, 2026 ten Bosch John Roderick SVP of Laboratory Operations Sell 1,417 92.86 131,583
Aug 10, 2026 Tsao David Chief Technology Officer Sell 10,000 92.86 928,600
Aug 10, 2026 Tsao David Chief Technology Officer Other 10,000 2.80 28,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?